- Supported exchanges /
- AU /
- PAA.AU
PharmAust Ltd (PAA AU) stock market data APIs
PharmAust Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. PharmAust Limited was incorporated in 2000 and is based in Melbourne, Australia.
PharmAust Ltd Financial Data Overview
| 0.18 | |
| 0.17 | |
| - | |
| 0.18 | |
| 0.17 | |
| 0.068-0.535 | |
| 82 691 K | |
| 486 M | |
| 842 K | |
| 1.551 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
PharmAust Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 842 K
- EBITDA -5 815 276
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get PharmAust Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get PharmAust Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
